📊 OPK Key Takeaways
Is Opko Health, Inc.. (OPK) a Good Investment?
OPKO Health is operationally distressed with a -41% operating margin, declining revenue (-14.9% YoY), and negative free cash flow of -$21.1M despite maintaining a solid balance sheet. The company is consuming cash reserves to fund operations and lacks profitability visibility, presenting significant fundamental risks.
Fundamentals have deteriorated with double-digit revenue decline, widening losses, and deeply negative operating and free cash flow. While liquidity and leverage are favorable, the lack of interest coverage and unclear path to profitability make the risk/reward unattractive until cash burn abates and revenues stabilize.
Opko Health, Inc.. Key Strengths (OPK)
- Strong balance sheet with $1.2B stockholders' equity
- Excellent liquidity ratios (3.61x current, 3.17x quick) providing operational cushion
- Moderate leverage with 0.29x debt-to-equity ratio
- Reasonable gross margin of 36.8% suggests product viability
- Strong liquidity (current/quick ~4x/3.5x)
- Moderate leverage with sizable cash balance
- Decent gross margin providing operating leverage potential
OPK Stock Risks: Opko Health, Inc.. Investment Risks
- Severe operating losses of -$51.0M on declining $124.2M revenue base
- Negative operating cash flow (-$19.3M) and free cash flow (-$21.1M) indicate unsustainable cash burn
- Declining revenue trajectory (-14.9% YoY) with no apparent stabilization
- Net losses of -$54.8M consuming balance sheet reserves; long-term sustainability questionable
- Sustained negative OCF and FCF indicating cash burn
- Revenue down 14.9% YoY, weakening top-line
- No interest coverage; potential dilution or refinancing risk if burn persists
Key Metrics to Watch
- Operating cash flow trend - must return to positive
- Revenue stabilization and growth trajectory
- Operating margin recovery path and timeline to profitability
- Operating cash flow (TTM trend)
- Revenue growth (YoY)
Opko Health, Inc.. (OPK) Financial Metrics & Key Ratios
💡 AI Analyst Insight
Strong liquidity with a 3.61x current ratio provides a solid financial cushion.
OPK Profit Margin, ROE & Profitability Analysis
OPK vs Healthcare Sector: How Opko Health, Inc.. Compares
How Opko Health, Inc.. compares to Healthcare sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Opko Health, Inc.. Stock Overvalued? OPK Valuation Analysis 2026
Based on fundamental analysis, Opko Health, Inc.. has mixed fundamental signals relative to the Healthcare sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Opko Health, Inc.. Balance Sheet: OPK Debt, Cash & Liquidity
OPK Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: Opko Health, Inc..'s revenue has declined by 51% over the 5-year period, indicating business contraction. The most recent EPS of $-0.25 indicates the company is currently unprofitable.
OPK Revenue Growth, EPS Growth & YoY Performance
OPK Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $124.2M | -$54.8M | $-0.07 |
| Q3 2025 | $151.7M | $21.6M | $0.03 |
| Q2 2025 | $156.8M | -$10.3M | $-0.01 |
| Q1 2025 | $150.0M | -$67.6M | N/A |
| Q3 2024 | $173.6M | $24.9M | $0.03 |
| Q2 2024 | $182.2M | -$10.3M | N/A |
| Q1 2024 | $173.7M | -$18.3M | N/A |
| Q3 2023 | $178.6M | -$84.5M | N/A |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
Opko Health, Inc.. Dividends, Buybacks & Capital Allocation
OPK SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Opko Health, Inc.. (CIK: 0000944809)
📋 Recent SEC Filings
❓ Frequently Asked Questions about OPK
What is the AI rating for OPK?
Opko Health, Inc.. (OPK) has a Combined AI Grade of C from Claude (C) and ChatGPT (C) with 74% combined confidence, based on fundamental analysis of SEC EDGAR filings.
What are OPK's key strengths?
Claude: Strong balance sheet with $1.2B stockholders' equity. Excellent liquidity ratios (3.61x current, 3.17x quick) providing operational cushion. ChatGPT: Strong liquidity (current/quick ~4x/3.5x). Moderate leverage with sizable cash balance.
What are the risks of investing in OPK?
Claude: Severe operating losses of -$51.0M on declining $124.2M revenue base. Negative operating cash flow (-$19.3M) and free cash flow (-$21.1M) indicate unsustainable cash burn. ChatGPT: Sustained negative OCF and FCF indicating cash burn. Revenue down 14.9% YoY, weakening top-line.
What is OPK's revenue and growth?
Opko Health, Inc.. reported revenue of $124.2M.
Does OPK pay dividends?
Opko Health, Inc.. pays dividends, with $4.7M distributed to shareholders in the trailing twelve months.
Where can I find OPK SEC filings?
Official SEC filings for Opko Health, Inc.. (CIK: 0000944809) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is OPK's EPS?
Opko Health, Inc.. has a diluted EPS of $-0.07.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined grade reflects both perspectives for balanced insights.
What is OPK's fundamental grade?
Based on our AI fundamental analysis in May 2026, Opko Health, Inc.. has a C grade with 74% confidence. Review the strengths and risks sections above for full context. This is not investment advice.
Is OPK stock overvalued or undervalued?
Valuation metrics for OPK: ROE of -4.6% (sector avg: 15%), net margin of -44.2% (sector avg: 12%). Compare these metrics with sector averages to assess valuation.
What is OPK's AI grade for 2026?
Our dual AI analysis gives Opko Health, Inc.. a combined C grade for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is OPK's free cash flow?
Opko Health, Inc..'s operating cash flow is $-19.3M, with capital expenditures of $1.8M. FCF margin is -17.0%.
How does OPK compare to other Healthcare stocks?
Vs Healthcare sector averages: Net margin -44.2% (avg: 12%), ROE -4.6% (avg: 15%), current ratio 3.61 (avg: 2).